AR105029A1 - Composición farmacéutica que comprende derivado de ácido graso - Google Patents

Composición farmacéutica que comprende derivado de ácido graso

Info

Publication number
AR105029A1
AR105029A1 ARP160101808A ARP160101808A AR105029A1 AR 105029 A1 AR105029 A1 AR 105029A1 AR P160101808 A ARP160101808 A AR P160101808A AR P160101808 A ARP160101808 A AR P160101808A AR 105029 A1 AR105029 A1 AR 105029A1
Authority
AR
Argentina
Prior art keywords
hydroxy
group
halogen
aliphatic hydrocarbon
substituted
Prior art date
Application number
ARP160101808A
Other languages
English (en)
Original Assignee
Sucampo Ag
R-Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag, R-Tech Ueno Ltd filed Critical Sucampo Ag
Publication of AR105029A1 publication Critical patent/AR105029A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Reivindicación 1: Una composición farmacéutica oral que comprende: (a) un derivado de ácido graso representado por la fórmula (1) donde L, M y N son hidrógeno, hidroxi, halógeno, alquilo inferior, hidroxialquilo inferior, alcanoiloxi inferior u oxo, donde por lo menos uno de L y M es un grupo diferente de hidrógeno, y el anillo de cinco miembros puede tener por lo menos un enlace doble; A es -CH₃, o -CH₂OH, -COCH₂OH, -COOH o un derivado funcional de estos; B es un enlace único, -CH₂-CH₂-, -CH=CH-, -CºC-, -CH₂-CH₂-CH₂-, -CH=CH-CH₂-, -CH₂-CH=CH-, -CºC-CH₂- o -CH₂-CºC-; Z es un compuesto del grupo de fórmulas (2) o enlace único, donde R⁴ y R⁵ son hidrógeno, hidroxi, halógeno, alquilo inferior, alcoxi inferior o hidroxialquilo inferior, donde R⁴ y R⁵ no son hidroxi y alcoxi inferior al mismo tiempo; R¹ es un residuo hidrocarburo alifático medio o inferior bivalente saturado o insaturado, que no está sustituido o está sustituido con halógeno, alquilo inferior, hidroxi, oxo, arilo o grupo heterocíclico, y por lo menos uno de los átomos de carbono en el hidrocarburo alifático está opcionalmente sustituido con oxígeno, nitrógeno o azufre; y Rᵃ es un residuo hidrocarburo alifático medio o inferior, saturado o insaturado, que no está sustituido o está sustituido con halógeno, oxo, hidroxi, alquilo inferior, alcoxi inferior, alcanoiloxi inferior, cicloalquilo inferior, cicloalquiloxi inferior, arilo, ariloxi, grupo heterocíclico o grupo heterocíclico-oxi; alcoxi inferior; alcanoiloxi inferior; cicloalquilo inferior; cicloalquiloxi inferior; arilo; ariloxi; grupo heterocíclico; grupo heterocíclico-oxi, y por lo menos uno de los átomos de carbono en el hidrocarburo alifático está opcionalmente sustituido con oxígeno, nitrógeno o azufre; (b) un agente edulcorante seleccionado del grupo que consiste en neotame, sacarina, sucralosa y una de sus mezclas; y (c) un vehículo oleoso farmacéuticamente aceptable. Reivindicación 6: La composición como se describe en la reivindicación 1, donde el derivado de ácido graso es ácido (-)-7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentil)-2-hidroxi-6-oxooctahidrociclopenta[b]piran-5-il]heptanoico o ácido (-)-7-{(2R,4aR,5R,7aR)-2-[(3S)-1,1-difluoro-3-metilopentil]-2-hidroxi-6-oxooctahidrociclopenta[b]piran-5-il}heptanoico.
ARP160101808A 2015-06-19 2016-06-16 Composición farmacéutica que comprende derivado de ácido graso AR105029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562182084P 2015-06-19 2015-06-19

Publications (1)

Publication Number Publication Date
AR105029A1 true AR105029A1 (es) 2017-08-30

Family

ID=56852296

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101808A AR105029A1 (es) 2015-06-19 2016-06-16 Composición farmacéutica que comprende derivado de ácido graso

Country Status (4)

Country Link
US (1) US20170020890A1 (es)
AR (1) AR105029A1 (es)
TW (1) TW201705952A (es)
WO (1) WO2016203317A1 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
DE69714698T2 (de) 1996-06-10 2002-12-05 Sucampo Ag Endothelin-antagonisten
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
CA2870252A1 (en) * 2012-04-23 2013-10-31 Sucampo Ag Method for treating irritable bowel syndrome with diarrhea

Also Published As

Publication number Publication date
TW201705952A (zh) 2017-02-16
US20170020890A1 (en) 2017-01-26
WO2016203317A1 (en) 2016-12-22

Similar Documents

Publication Publication Date Title
AR103969A1 (es) Inmunomoduladores
AR092955A1 (es) Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona
PE20220948A1 (es) Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen
PE20181045A1 (es) Compuestos utiles como inmunomoduladores
PE20130155A1 (es) Derivados de ariletinilo
PE20161031A1 (es) Agentes citotoxicos bifuncionales
CO6300866A2 (es) Derivado de imidazopiridin - 2 - on
EA201692010A1 (ru) Фармацевтическое соединение
GT200600165A (es) Derivados dihidrobenzofuranos y usos de los mismos
PE20160844A1 (es) Compuestos triciclicos como agentes anticancerigenos
CO6231036A2 (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
AR061369A1 (es) Derivados de pirimidina y composiciones farmaceuticas que los comprenden
CO6150164A2 (es) Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor
AR079205A1 (es) Morfolinotiazoles como moduladores alostericos positivos alfa 7
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
ECSP11011318A (es) Derivados de benzofurano
AR100418A1 (es) Compuestos y composiciones para inducir condrogénesis
AR094812A1 (es) Derivado de piridina monocíclico como inhibidor del fgfr
CO2018010787A2 (es) Compuesto de griseofulvina
DOP2010000022A (es) Derivados de pirimidina 934
BR112015018509A2 (pt) compostos de imidazo piridina
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR090572A1 (es) Derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CO6420338A2 (es) Compuesto ciclico que contiene heteroatomos
AR102258A1 (es) Compuestos de quinolina y quinazolina

Legal Events

Date Code Title Description
FB Suspension of granting procedure